Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a multisystem disease characterized by chronic inflammation and damage to vital organs and systems. Despite the great success achieved in the treatment of SLE, glucocorticoids (GC) remain one of the main methods of therapy. The GC toxicity index is an objective...
Saved in:
| Main Authors: | N. Yu. Nikishina, E. V. Ermolaeva, A. A. Mesnyankina, E. A. Aseeva, S. K. Soloviev, B. Sh. Isaeva, G. M. Koylubaeva, A. M. Lila |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1238 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01) -
Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2020-03-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?
by: S. K. Soloviev, et al.
Published: (2022-02-01) -
GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS
by: N. V. Seredavkina, et al.
Published: (2014-11-01)